搜索临床试验以:Recurrent Platinum-Resistant
总计11891个结果
-
Institut du Cancer de Montpellier - Val d'Aurelle完全的
-
Institut du Cancer de Montpellier - Val d'Aurelle完全的
-
Hoag Memorial Hospital PresbyterianCancer Biotherapy Research Group完全的
-
Hoag Memorial Hospital PresbyterianCancer Biotherapy Research Group完全的
-
Hoag Memorial Hospital PresbyterianCancer Biotherapy Research Group完全的淋巴瘤 | 骨髓增生异常综合征 | 白血病 | 慢性骨髓增生性疾病 | 未明确的成人实体瘤,特定方案 | 多发性骨髓瘤和浆细胞肿瘤 | 癌前/非恶性疾病美国
-
Hoag Memorial Hospital PresbyterianCancer Biotherapy Research Group完全的
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)完全的
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Bristol-Myers Squibb完全的乳腺癌 | 转移美国, 西班牙, 比利时, 秘鲁, 意大利, 阿根廷, 法国
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Bristol-Myers Squibb完全的
-
Theradex未知
-
European Organisation for Research and Treatment...Cancer Research UK; Australasian Gastro-Intestinal Trials Group; Arbeitsgruppe Lebermetastasen... 和其他合作者未知
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)完全的
-
Teva Branded Pharmaceutical Products R&D, Inc.完全的
-
INSYS Therapeutics IncGeorgetown University完全的
-
NYU Langone HealthNational Cancer Institute (NCI)完全的
-
NYU Langone HealthNational Cancer Institute (NCI)完全的
-
The Cleveland ClinicNational Cancer Institute (NCI)完全的
-
NYU Langone HealthNational Cancer Institute (NCI)完全的
-
NYU Langone HealthNational Cancer Institute (NCI)完全的
-
NYU Langone HealthNational Cancer Institute (NCI)完全的
-
NYU Langone HealthNational Cancer Institute (NCI)完全的
-
NYU Langone HealthNational Cancer Institute (NCI)完全的